Testing effectiveness (Phase 2)Study completedNCT02640807What this trial is testingIL-7 to Restore Absolute Lymphocyte Counts in Sepsis PatientsWho this might be right forSevere Sepsis With Septic Shock Revimmune 27
Not applicableStudy completedNCT00086476What this trial is testingStudy of Megakaryocytes From Patients With Abnormal Platelet VesiclesWho this might be right forBlood Coagulation Disorders National Human Genome Research Institute (NHGRI) 3
Not applicableStudy completedNCT02799251What this trial is testingAssessment of Postoperative Lymphopenia as Risk Factor for Postoperative InfectionsWho this might be right forCancer of the Digestive SystemThoracic Diseases Centre Hospitalier Universitaire de Saint Etienne 1,125
Testing effectiveness (Phase 2)UnknownNCT04371939What this trial is testingEfficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich SyndromeWho this might be right forWiskott-Aldrich Syndrome Federal Research Institute of Pediatric Hematology, Oncology and Immunology 30
Testing effectiveness (Phase 2)Temporarily pausedNCT03312244What this trial is testingPyridostigmine as Immunomodulator in People Living With HIVWho this might be right forHIV-1-infectionCD4+ T LymphocytopeniaImmune Deficiency+1 more Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 60
Testing effectiveness (Phase 2)Study completedNCT00919503What this trial is testingTreosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited DisordersWho this might be right forNon-Neoplastic Hematologic and Lymphocytic Disorder Fred Hutchinson Cancer Center 98
Not applicableLooking for participantsNCT03394053What this trial is testingThe Mechanistic Biology of Primary Immunodeficiency DisordersWho this might be right forPrimary Immunodeficiency Disorders National Institute of Allergy and Infectious Diseases (NIAID) 2,500
Large-scale testing (Phase 3)Study completedNCT00278954What this trial is testingEfficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.Who this might be right forPrimary ImmunodeficiencyCommon Variable HypogammaglobulinemiaX-linked Hypogammaglobulinemia+3 more Bio Products Laboratory 50
Not applicableStudy completedNCT03158987What this trial is testingRegional Differences in Human Immunodeficiency Virus (HIV) TestingWho this might be right forHIV SeropositivityCD4+ T Lymphocytopenia Jena University Hospital 999
Not applicableStudy completedNCT04756687What this trial is testingReal World Analysis on Lymphocyte Reconstitution After Lymphopenia in Participants Treated by TecfideraWho this might be right forMultiple SclerosisMultiple Sclerosis, Relapsing-Remitting Biogen 1,507
Not applicableUnknownNCT00006319What this trial is testingMolecular and Clinical Studies of Primary Immunodeficiency DiseasesWho this might be right forWiskott- Aldrich SyndromeADA Deficient SCID National Human Genome Research Institute (NHGRI) 266
Testing effectiveness (Phase 2)Looking for participantsNCT07258160What this trial is testingEvaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid TumorsWho this might be right forSolid CancerLymphopenia Second Affiliated Hospital of Soochow University 127
Testing effectiveness (Phase 2)Ended earlyNCT03821038What this trial is testingRecombinant Interleukin-7 (CYT107) to Restore Absolute Lymphocyte Counts in Sepsis PatientsWho this might be right forSepsis, Severe Revimmune 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT02333760What this trial is testingLong Term Safety Follow up of Haematopoietic Stem Cell Gene Therapy for the Wiskott Aldrich SyndromeWho this might be right forWiskott-Aldrich Syndrome Genethon 10
Testing effectiveness (Phase 2)Ended earlyNCT00909363What this trial is testingThrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) PatientsWho this might be right forWiskott-Aldrich SyndromeThrombocytopeniaBleeding Weill Medical College of Cornell University 24
Large-scale testing (Phase 3)Active Not RecruitingNCT03837483What this trial is testingA Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects With Wiskott-Aldrich SyndromeWho this might be right forWiskott-Aldrich Syndrome Fondazione Telethon 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04019262What this trial is testingShort Course Chemo-Radiation Therapy for Patients With Newly Diagnosed GlioblastomaWho this might be right forGlioblastoma John Flickinger 2
Not applicableAvailableNCT06956547What this trial is testingExpanded Access Use of Nogapendekin-alfa Inbakicept in the Reversal and Maintenance of Absolute Lymphocyte Count (ALC) for the Treatment of Lymphopenia Induced by Chemotherapy, Immunotherapy, and/or Radiation TherapyWho this might be right forLymphopenia ImmunityBio, Inc.
Not applicableStudy completedNCT01653834What this trial is testingFeasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade GliomasWho this might be right forGlioblastoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 10
Testing effectiveness (Phase 2)Ended earlyNCT04927169What this trial is testingInterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection (Brazil Cohort)Who this might be right forCOVID-19Lymphocytopenia Revimmune 4